Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9796
+0.0696 (7.65%)
At close: Oct 9, 2026, 4:00 PM EDT
0.9500
-0.0296 (-3.02%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Werewolf Therapeutics Revenue
Werewolf Therapeutics had revenue of $21.00M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $21.00M. That makes Werewolf Therapeutics the 33,501st largest company in the world by revenue and 4,407th in the United States.
Revenue (ttm)
$21.00M
Revenue Growth
n/a
P/S Ratio
2.27
Revenue / Employee
$1,500,000
Employees
14
Market Cap
47.61M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 1.89M | -18.06M | -90.55% |
| Dec 31, 2023 | 19.94M | 3.54M | 21.60% |
| Dec 31, 2022 | 16.40M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 34.59M |
| Celularity | 18.97M |
| Caribou Biosciences | 10.04M |
| Apollomics | 8.84M |
| ImageneBio | 800.00K |
| CervoMed | 331.30K |
| eXoZymes | -700.00 |
HOWL News
- 16 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX) - GlobeNewsWire
- 4 weeks ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX) - GlobeNewsWire
- 6 weeks ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ) - GlobeNewsWire
- 7 weeks ago - Why Werewolf Therapeutics stock exploded higher and what comes next? - Invezz
- 7 weeks ago - Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today? - TipRanks
- 7 weeks ago - Werewolf Therapeutics, Ambros Therapeutics to combine in all-stock transaction - TheFly
- 7 weeks ago - Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement - GlobeNewsWire
- 2 months ago - Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire